104 related articles for article (PubMed ID: 1707769)
1. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression.
Salamone MC; Roisman FR; Santiago J; Satz ML; Fainboim L
Dis Markers; 1990; 8(5):265-74. PubMed ID: 1707769
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. II. Intracellular detection of CD1 antigens.
Salamone MC; Roisman FR; Morelli AE; Noli MI; Fainboim L
Dis Markers; 1990; 8(5):275-81. PubMed ID: 1707770
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
4. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
6. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
8. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
9. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
[TBL] [Abstract][Full Text] [Related]
10. Leu-M1 antigen expression in acute leukaemias.
de Mascarel A; Coindre JM; de Mascarel I; David B; Trojani M; Broustet A
J Pathol; 1987 Nov; 153(3):225-32. PubMed ID: 3501459
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
Kawai S; Zha Z; Yamamoto Y; Nakadate H; Kawakami K; Kikuta A; Utsumi J; Nishikawa K; Mimaya J; Miyake M
Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
[TBL] [Abstract][Full Text] [Related]
14. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
Marinov J; Koubek K; Starý J
Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
[TBL] [Abstract][Full Text] [Related]
16. The MHC class I associated beta 2-microglobulin (beta 2m) light chain is expressed in a molar excess over HLA-ABC and CD1 on the membrane of leukaemic B cells but not leukaemic T cells: evidence for further beta 2m-associated molecules.
Jones RA; Child JA; Master PS; Scott CS
Scand J Immunol; 1991 Jul; 34(1):53-61. PubMed ID: 1712510
[TBL] [Abstract][Full Text] [Related]
17. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
Rani S; De Oliveira MS; Catovsky D
Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
[TBL] [Abstract][Full Text] [Related]
18. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
[TBL] [Abstract][Full Text] [Related]
19. Characterization of HLA-DR antigens on leukaemic cells.
Newman RA; Greaves MF
Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
[TBL] [Abstract][Full Text] [Related]
20. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]